TRACON PHARMACEUTICALS INC - COM NEW (TCON) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q2 2024

Type / Class
Equity / COM NEW
Symbol
TCON on OTC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$1,390,736 0
2024 Q1 3,245,454 $1,390,736 -$51,872 $0.43 28
2023 Q4 5,163,108 $903,416 -$741,070 $0.18 22
2023 Q3 9,312,834 $1,657,737 -$181,088 $0.18 19
2023 Q2 9,959,933 $2,898,027 -$181,617 $0.29 25
2023 Q1 9,949,661 $18,804,849 +$445,136 $1.89 31
2022 Q4 9,823,276 $14,635,876 -$116,055 $1.49 32
2022 Q3 9,859,600 $16,462,000 -$19,428 $1.67 28
2022 Q2 9,870,332 $19,740,000 +$1,422,402 $2.00 29
2022 Q1 9,130,915 $24,013,000 -$82,595 $2.63 34
2021 Q4 9,159,656 $25,365,000 -$3,919,053 $2.77 35
2021 Q3 10,231,356 $39,596,000 +$3,027,966 $3.87 43
2021 Q2 9,016,095 $58,511,000 -$1,612,719 $6.49 43
2021 Q1 8,845,328 $72,793,000 +$5,188,802 $8.23 40
2020 Q4 8,485,126 $99,279,000 +$32,500,450 $11.70 37
2020 Q3 5,749,655 $29,725,000 +$22,322,775 $5.17 26
2020 Q2 1,553,892 $3,047,000 +$581,226 $1.96 18
2020 Q1 1,266,231 $2,141,000 +$810,956 $1.70 18
2019 Q4 777,034 $1,820,000 +$1,623,000 $2.34 12